NFAT and MEF-2 Choreograph Bladder Wall Remodeling Following Partial Outlet Obstr

NFAT 和 MEF-2 编排部分出口阻塞后的膀胱壁重塑

• 批准号: 7943043
• 负责人: Stephen Anthony Zderic
• 金额: $ 32.5万
• 依托单位: CHILDREN'S HOSP OF PHILADELPHIA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2011-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7943043
• 关键词: Address; Affect; Age; Alternative Splicing; Anatomy; Animals; Antibodies; Area; Autoradiography; Back; Binding; Binding Sites; Bladder; Bladder Tissue; Calcineurin; Calcineurin Pathway; Calcium; Cell Culture Techniques; Cell Fraction; Cell Line; Cell Nucleus; Cell Wall; Cells; Cellular Stress; Child; Childhood; Clinical; Clinical Trials; Complement; Complex; Critical Pathways; Cultured Cells; Cyclosporine; DNA biosynthesis; Data; Detection; Development; Etiology; Fibroblasts; Fibrosis; Gene Family; Gene Targeting; Genes; Genetic Transcription; Homeostasis; Human; Human Cell Line; Hyperplasia; Hypertrophy; Implant; In Situ; In Vitro; Kidney; Kidney Failure; Lead; Left; Luciferases; Measures; Mechanics; Mediating; Medical; Messenger RNA; Methods; Microtomy; Modeling; Molecular; Molecular Analysis; Monitor; Morbidity - disease rate; Morphology; Mus; Muscle; Muscle Cells; Myocardium; Myosin Heavy Chains; N-terminal; Neurogenic Bladder; Normal Range; Nuclear; Nuclear Envelope; Nuclear Translocation; Obstruction; Organ; Oryctolagus cuniculus; Pathway interactions; Patients; Pattern; Performance; Physiological; Plasmids; Population; Process; Protein Isoforms; Proteins; Publishing; Pump; Reporter; Role; Run-On Assays; Screening procedure; Secondary to; Signal Transduction; Site; Smooth Muscle; Smooth Muscle Myocytes; Smooth Muscle Myosins; Spinal; Spinal Dysraphism; Staging; Staining method; Stains; Stretching; System; Techniques; Testing; Thymidine; Time; Transgenic Mice; Up-Regulation; Ureter; Urethra; Urinary Incontinence; Urine; Urothelium; Western Blotting; Work; Workload; activating transcription factor; base; calcineurin phosphatase; chromatin immunoprecipitation; enhancing factor; gel mobility shift assay; human MYH11 protein; human disease; improved; in vitro Model; in vivo; inhibitor/antagonist; male; mouse model; muscle hypertrophy; nuclear factors of activated T-cells; pressure; prevent; promoter; public health relevance; randomized trial; research study; response; therapeutic target; therapy design; tissue/cell culture; transcription factor; transcription factor NF-AT c3; uptake; urologic

DESCRIPTION (provided by applicant): In response to partial outlet obstruction, the urinary bladder is capable of undergoing hypertrophy via a complex remodeling process that allows it to adapt to its new workload. This remodeling is driven by a number of signaling cascades and their corresponding transcription factors. This proposal focuses on the role of the calcineurin pathway and its associated transcription factors the Nuclear Factor of Activated T Cells (NFAT) and Myocyte Enhancing Factor 2 (MEF-2). Preliminary data support our central hypothesis that partial bladder outlet obstruction is associated with dysregulation of intracellular calcium homeostasis and activation of calcineurin and the subsequent nuclear importation of NFAT. With administration of cyclosporine A (CSA), the resulting bladder hypertrophy is diminished, and there is a reversal of the myosin heavy chain (MHC) mRNA isoforms back towards a normal expression pattern. We propose to further study these observations in a murine model of partial bladder outlet obstruction using a transgenic mouse containing an NFAT-luciferase reporter construct in the presence and absence of CSA administered of varying time points. End points will include bladder mass, in vitro determinations of contractility and shortening velocity, morphology, and a molecular analysis of MHC isoform expression. We also seek to localize in situ, which bladder wall cell population(s) show evidence of calcineurin activation. We also seek to localize the sites where DNA synthesis is taking place within the bladder wall and determine whether these sites of DNA synthesis represent fibroblasts, smooth muscle cells, or both. These in vivo experiments are complemented by in vitro experiments using cultured cells to assess the impact of mechanical deformation upon NFAT and MEF- 2 translocation to the nucleus. This approach will allow for in vitro screening of compounds that can prevent calcineurin activation, and will allow for study of the interaction between NFAT, MEF-2 and the smooth muscle MHC promoter. Using microarray methods we propose to identify the NFAT and MEF-2 responsive target genes within two cell populations; bladder smooth muscle and bladder fibroblasts. The relevance of this proposed work to human disease is apparent when one considers the socially devastating sequelae of urinary incontinence and renal failure that may result from untreated bladder wall hypertrophy. PUBLIC HEALTH RELEVANCE: Human Relevance - Two conditions can result in severe bladder wall hypertrophy in children, posterior urethral valves, and spinal bifida. If left untreated bladder wall hypertrophy leads to the socially devastating sequelae of urinary incontinence and in extreme cases renal failure may result as the bladder loses its ability to store urine at low pressures. New therapy to preserve and enhance native bladder function will help avoid the development of the end stage bladder.

描述（由申请人提供）：作为对部分出口阻塞的反应，膀胱能够通过复杂的重塑过程进行肥大，使其能够适应新的工作量。这种重塑是由许多信号级联及其相应的转录因子驱动的。本研究的重点是钙调磷酸酶途径及其相关转录因子活化T细胞核因子（NFAT）和肌细胞增强因子2 （MEF-2）的作用。初步数据支持我们的中心假设，即部分膀胱出口梗阻与细胞内钙稳态失调和钙调磷酸酶激活以及随后的NFAT核输入有关。服用环孢素A （CSA）后，膀胱肥大减轻，肌球蛋白重链（MHC） mRNA亚型向正常表达模式逆转。我们建议在小鼠部分膀胱出口梗阻模型中进一步研究这些观察结果，使用含有nfat -荧光素酶报告结构的转基因小鼠，在不同时间点给予CSA存在和不存在的情况下。终点将包括膀胱质量、体外收缩性和缩短速度测定、形态学和MHC异构体表达的分子分析。我们也寻求原位定位，膀胱壁细胞群(s)显示钙调磷酸酶激活的证据。我们还试图定位发生在膀胱壁内的DNA合成位点，并确定这些DNA合成位点是代表成纤维细胞、平滑肌细胞，还是两者兼而有之。这些体内实验与体外培养细胞实验相辅相成，以评估机械变形对NFAT和MEF- 2向细胞核转运的影响。这种方法将允许体外筛选可以阻止钙调磷酸酶激活的化合物，并将允许研究NFAT， MEF-2和平滑肌MHC启动子之间的相互作用。我们建议使用微阵列方法鉴定两个细胞群体中的NFAT和MEF-2应答靶基因；膀胱平滑肌和膀胱成纤维细胞。当人们考虑到未经治疗的膀胱壁肥大可能导致的尿失禁和肾衰竭的社会破坏性后遗症时，这项拟议的工作与人类疾病的相关性是显而易见的。